Skip to main content

Endothelin contraction in pig coronary artery: Receptor types and Ca2+-mobilization

  • Chapter
The Cellular Basis of Cardiovascular Function in Health and Disease

Part of the book series: Developments in Molecular and Cellular Biochemistry ((DMCB,volume 22))

  • 110 Accesses

Abstract

Endothelin is one of the most potent vasoconstrictors known. It plays an important role in the regulation of vascular tone and in the development of many cardiovascular diseases. This study focuses on the receptor types and the Ca2+ mobilization responsible for endothelin-1 (ET-1) contraction in de-endothelialized pig coronary artery rings. ET-1 contracted the artery rings with an EC50 = 6.5 ± 1 nM and a maximum contraction which was 98.6 ± 9% of the contraction produced by 60 mM KC1. BQ123 (5 μM), an ETA antagonist, reversed 78 ± 3% of the ET-1 contraction (50 nM). IRL1620, a selective ETB agonist, produced 23 ± 3% of the total ET-1 contraction with an EC50= 12.7 ± 2 nM. More than 85% of the contraction due to 100 nM IRL 1620 was inhibited by 200 nMBQ788, an ETB antagonist. Therefore, approximately 80% of the ET-1 contraction in this artery occurred via ETA receptors, and the other 20% was mediated by ETB receptors. To assess the Ca2+ pools utilized during the ET-1 response, ET-1 contraction was also examined in medium containing an L-type Ca2+ channel blocker nitrendipine, and in Ca2+ free medium containing 0.2 mM EGTA. In Ca2+ containing medium the contraction elicited by ET-1 was 98.6 ± 9% of the KC1 contraction, however, in the presence 10 µM nitrendipine the ET-1 induced contraction was 54 ± 7% of the KC1 contraction, and in Ca2+-free medium it was 13 ± 2%. Similarly, the IRL 1620 contractions in Ca2+ containing medium, in the presence of nitrendipine and in Ca2+-free medium were 22.4 ± 3%, 12 ± 3% and 11 ± 2% of the KC1 response respectively. Thus, both ETA and ETB contractions utilize extracellular Ca2+ pools via L-type Ca2+ channels and other undefined route(s), as well as intracellular Ca2+ pools. In the pig coronary artery smooth muscle, ET-1 contractions occur predominantly via ETA receptors, with ETB receptors using similar Ca2+ mobilization pathways, but the ETB receptors appear to use the intracellular Ca2+ stores to a greater extent. (Mol Cell Biochem 176: 29–33, 1997)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

ET-1:

endothelin-1

EGTA:

ethyl glycol-bis(β-aminoethyl ether)-N,N,N’,N’-tetraacetic acid

References

  1. Van Renterghem C, Vigne P, Barhanin J, Schmid-Alliana A, Freiin C, Lazdunski M: Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem and Biophys Res Comm 157: 977–985, 1988

    Article  Google Scholar 

  2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K: The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Nat Acad Sci USA 86: 2863–2867, 1989

    Article  PubMed  CAS  Google Scholar 

  3. White DG, Cannon TR, Garratt H, Mundin JW, Summer MJ, Watts IS: Endothelin ETA and ETB receptors mediate vascular smooth-muscle contraction. J Cardiovasc Pharmacol 22: S144–S148, 1993

    Article  PubMed  CAS  Google Scholar 

  4. Bacon CR, Davenport AP: Endothelin receptors in human coronary artery and aorta. Br J Pharmacol 117: 986–992, 1996

    Article  PubMed  CAS  Google Scholar 

  5. Tonnessen T, Naess PA, Kirkeboen KA, Offstad J, Ilebekk A, Christensen G: Endothelin is released from the porcine coronary

    Google Scholar 

  6. Moreland S, McMullen D, Abboa-Offei B, Seymour A: Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature. Brit Jour Pharmacol 112: 704–708, 1994

    Article  CAS  Google Scholar 

  7. Pollock DM, Opgenorth TJ: ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Brit Jour Pharmacol 111: 729–732, 1994

    Article  CAS  Google Scholar 

  8. Godfraind T: Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Brit Jour Pharmacol 110: 1201–1205, 1993

    Article  CAS  Google Scholar 

  9. Takigawa M, Sakurai T, Kasuya Y, Abe Y, Masaki T, Goto K: Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors. European Jour Biochem 228: 102–108, 1995

    Article  CAS  Google Scholar 

  10. Goto K, Kasuya Y, Matsuki N, Takuwa Y, Kurihara H, Ishikawa T, Yanagisawa M, Masaki T: Endothelin activates the dihydropyridine-sensitive, voltage-dependent Ca2+ channel in vascular smooth muscle. Proc Nat Acad Sci USA 86: 3915–3918, 1989

    Article  PubMed  CAS  Google Scholar 

  11. Wagner-Mann C, Bowman L, Sturek M: Primary action of endothelin on Ca release in bovine coronary artery smooth muscle cells. Am J Physiol 260: C763–C770, 1991

    PubMed  CAS  Google Scholar 

  12. Grover AK, Fomin VP, Samson SE: Angiotensin II contractions in coronary artery: Nature of receptors and calcium pools. Mol Cell Biochem 135:11–19, 1994

    Article  PubMed  CAS  Google Scholar 

  13. Clarke JG, Benjamin N, Larkin SW, Webb DJ, Davies GJ, Maseri A: Endothelin is a potent long-lasting vasoconstrictor in men. Am J Physiol 257: H2033–H2033, 1989

    PubMed  CAS  Google Scholar 

  14. Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K, Urade Y, Inui T, Yamamura T, Okada T: A potent and specific agonist, Suc-[Glu9,Alal 1, 15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Comm 184: 953–959, 1992

    Article  PubMed  CAS  Google Scholar 

  15. Ihara M, Noguchi K, Saeki T, Fukuroda T, Tsuchida S, Kimura S, Ishikawa K, Nishikibe M, Yano M: Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 50: 247–255, 1992

    Article  PubMed  CAS  Google Scholar 

  16. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T et al.: Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Acad Sci USA 91: 4892–4896, 1994

    Article  CAS  Google Scholar 

  17. Maguire JJ, Kuc RE, O’Reilly G, Davenport AP: Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Brit Jour Pharmacol 113: 49–54, 1994

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Elmoselhi, A.B., Grover, A.K. (1997). Endothelin contraction in pig coronary artery: Receptor types and Ca2+-mobilization. In: Singal, P.K., Panagia, V., Pierce, G.N. (eds) The Cellular Basis of Cardiovascular Function in Health and Disease. Developments in Molecular and Cellular Biochemistry, vol 22. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5765-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5765-4_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7642-2

  • Online ISBN: 978-1-4615-5765-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics